Concourse Financial Group Securities’s Gain Therapeutics GANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 3155 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 4585 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 4574 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 4615 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 4618 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 4558 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 4498 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 4433 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 4315 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 4285 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 4087 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 4131 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 4075 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 4157 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 4081 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 3963 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 3875 |
|